“This grant support from Bristol Myers Squibb, a global biopharmaceutical company and pioneer in cell therapy, is anticipated to not only improve the educational experience at our college, but also strengthen the pipeline between education and career for many of our brilliant and diverse students,” said Paul W. Brandt-Rauf, ScD, MD, DrPH, dean of the School of Biomedical Engineering, Science and Health Systems.